Orazym Tablet is a combination pharmaceutical formulation containing Bromelain 96 mg, Trypsin 48 mg, and Rutoside 100 mg, designed to provide anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and exhibits anti-inflammatory and anti-edematous properties, making it effective in reducing swelling and pain associated with trauma, surgery, or inflammatory conditions. Trypsin, a serine protease enzyme, complements bromelain by promoting the degradation of inflammatory mediators and fibrin, thereby enhancing tissue repair and reducing inflammation. Rutoside, a bioflavonoid, acts as a potent antioxidant and capillary stabilizer, improving microcirculation and reducing capillary permeability, which aids in minimizing bruising and edema. The synergistic action of these components makes Orazym Tablet particularly useful in managing acute and chronic inflammatory states, including post-operative swelling, sports injuries, and vascular disorders characterized by capillary fragility. It is typically prescribed as an adjunct therapy to support faster recovery and alleviate symptoms related to inflammation and oxidative stress. Orazym should be used under medical supervision, considering potential contraindications and interactions with other medications.